Works by Allmann, Jakob

Results: 6

Pre-therapeutic comparative dosimetry of 177Lu-rhPSMA-7.3 and 177Lu-PSMA-I&T in patients with metastatic castration resistant prostate cancer (mCRPC).

Published in:

Journal of Nuclear Medicine, 2021, v. 62, n. 12, p. 1, doi. 10.2967/jnumed.121.262671

By:

Feuerecker, Benedikt;
Chantadisai, Maythinee;
Allmann, Anne;
Tauber, Robert;
Allmann, Jakob;
Steinhelfer, Lisa;
Rauscher, Isabel;
Wurzer, Alexander;
Wester, Hans-Jürgen;
Weber, Wolfgang A;
d'Alessandria, Calogero;
Eiber, Matthias

Publication type:

Article

Pre-therapeutic comparative dosimetry of 177Lu-rhPSMA-7.3 and 177Lu-PSMA-I&T in patients with metastatic castration resistant prostate cancer (mCRPC).

Published in:

Journal of Nuclear Medicine, 2021, v. 62, n. 11, p. 1, doi. 10.2967/jnumed.121.262671

By:

Feuerecker, Benedikt;
Chantadisai, Maythinee;
Allmann, Anne;
Tauber, Robert;
Allmann, Jakob;
Steinhelfer, Lisa;
Rauscher, Isabel;
Wurzer, Alexander;
Wester, Hans-Jürgen;
Weber, Wolfgang A.;
d’Alessandria, Calogero;
Eiber, Matthias

Publication type:

Article

Pre-therapeutic comparative dosimetry of 177Lu-rhPSMA-7.3 and 177Lu-PSMA-I&T in patients with metastatic castration resistant prostate cancer (mCRPC).

Published in:

Journal of Nuclear Medicine, 2021, v. 62, n. 10, p. 1, doi. 10.2967/jnumed.121.262671

By:

Feuerecker, Benedikt;
Chantadisai, Maythinee;
Allmann, Anne;
Tauber, Robert;
Allmann, Jakob;
Steinhelfer, Lisa;
Rauscher, Isabel;
Wurzer, Alexander;
Wester, Hans-Jürgen;
Weber, Wolfgang A.;
d’Alessandria, Calogero;
Eiber, Matthias

Publication type:

Article

Modeling and Predicting Tumor Response in Radioligand Therapy.

Published in:

Journal of Nuclear Medicine, 2019, v. 60, n. 1, p. 65, doi. 10.2967/jnumed.118.210377

By:

Kletting, Peter;
Thieme, Anne;
Eberhardt, Nina;
Rinscheid, Andreas;
D’Alessandria, Calogero;
Allmann, Jakob;
Wester, Hans-Jürgen;
Tauber, Robert;
Beer, Ambros J.;
Glatting, Gerhard;
Eiber, Matthias

Publication type:

Article

Radiation Dosimetry for 177Lu-PSMA I&T in Metastatic Castration-Resistant Prostate Cancer: Absorbed Dose in Normal Organs and Tumor Lesions.

Published in:

Journal of Nuclear Medicine, 2017, v. 58, n. 3, p. 445, doi. 10.2967/jnumed.116.178483

By:

Shozo Okamoto;
Thieme, Anne;
Allmann, Jakob;
D’Alessandria, Calogero;
Maurer, Tobias;
Retz, Margitta;
Tauber, Robert;
Heck, Matthias M.;
Wester, Hans-Juergen;
Tamaki, Nagara;
Fendler, Wolfgang P.;
Herrmann, Ken;
Pfob, Christian H.;
Scheidhauer, Klemens;
Schwaiger, Markus;
Ziegler, Sibylle;
Eiber, Matthias

Publication type:

Article

Novel telemetric signal averaging ECG approach to determine electrical atrial and ventricular conduction delays in implantable cardioverter defibrillator patients.

Published in:

Biomedical Engineering / Biomedizinische Technik, 2012, v. 57, n. S1, p. 1, doi. 10.1515/bmt-2012-4170

By:

Töpfer, Anja;
Wehsener, Ingolf;
Ismer, Bruno;
Kuehnert, Helmut;
Allmann, Jakob;
Eisentraeger, Daniela;
Figulla, Hans Reiner;
Heinke, Matthias

Publication type:

Article

Works by Allmann, Jakob

Pre-therapeutic comparative dosimetry of <sup>177</sup>Lu-rhPSMA-7.3 and <sup>177</sup>Lu-PSMA-I&T in patients with metastatic castration resistant prostate cancer (mCRPC).

Pre-therapeutic comparative dosimetry of <sup>177</sup>Lu-rhPSMA-7.3 and <sup>177</sup>Lu-PSMA-I&T in patients with metastatic castration resistant prostate cancer (mCRPC).

Pre-therapeutic comparative dosimetry of <sup>177</sup>Lu-rhPSMA-7.3 and <sup>177</sup>Lu-PSMA-I&T in patients with metastatic castration resistant prostate cancer (mCRPC).

Modeling and Predicting Tumor Response in Radioligand Therapy.

Radiation Dosimetry for <sup>177</sup>Lu-PSMA I&T in Metastatic Castration-Resistant Prostate Cancer: Absorbed Dose in Normal Organs and Tumor Lesions.

Novel telemetric signal averaging ECG approach to determine electrical atrial and ventricular conduction delays in implantable cardioverter defibrillator patients.